Later, Muller-Tidow et al. found that HER3 overexpression was associated with decreased survival time in lung cancer patients, and a further study by Ma et al. recapitulated these previous findings by noting that the overexpression of HER3 was observed in lung cancer cells but not normal lung cells [103,104]. Here, ERBB3 is linked to lung carcinoma.